KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ball (BALL) Cash & Equivalents (2016 - 2025)

Ball (BALL) has disclosed Cash & Equivalents for 17 consecutive years, with $1.2 billion as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 36.95% to $1.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.2 billion, a 36.95% increase, with the full-year FY2025 number at $1.2 billion, up 36.95% from a year prior.
  • Cash & Equivalents was $1.2 billion for Q4 2025 at Ball, up from $568.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.7 billion in Q1 2024 to a low of $13.0 million in Q2 2023.
  • A 5-year average of $775.4 million and a median of $569.5 million in 2021 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: plummeted 97.29% in 2023, then skyrocketed 10253.85% in 2024.
  • Ball's Cash & Equivalents stood at $563.0 million in 2021, then fell by 2.66% to $548.0 million in 2022, then increased by 26.82% to $695.0 million in 2023, then grew by 27.34% to $885.0 million in 2024, then soared by 36.95% to $1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for BALL's Cash & Equivalents are $1.2 billion (Q4 2025), $568.0 million (Q3 2025), and $296.0 million (Q2 2025).